GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Accounts Receivable

Medy-Tox (XKRX:086900) Accounts Receivable : ₩60,508 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Medy-Tox's accounts receivables for the quarter that ended in Dec. 2023 was ₩60,508 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Medy-Tox's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 81.19.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Medy-Tox's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was ₩-5,028.87.


Medy-Tox Accounts Receivable Historical Data

The historical data trend for Medy-Tox's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Accounts Receivable Chart

Medy-Tox Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56,487.48 34,164.60 28,702.89 44,998.25 60,507.72

Medy-Tox Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44,998.25 40,324.33 40,058.44 49,297.02 60,507.72

Medy-Tox Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Medy-Tox Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Medy-Tox's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=60507.719/68003.639*91
=81.19

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Medy-Tox's accounts receivable are only considered to be worth 75% of book value:

Medy-Tox's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(33345.129+0.75 * 60507.719+0.5 * 59617.915-137140.515
-220.328-5019.514)/6.73023
=-5,028.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Medy-Tox Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Medy-Tox (XKRX:086900) Business Description

Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines